13-07-2021
lucarista / shutterstock.com
The English High Court has cleared Roche of patent infringement claims over its line of insulin pumps but shot down the pharma giant’s attempt to invalidate the plaintiff’s patent.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
Roche, Insulet, English High Court, Insulin, Medical Devices, patents, patent infringement
Swiss big pharma settles patent dispute with Insulet
12-07-2022
Roche and Bluebird settle ‘Spark’ TM suit
19-05-2022
Roche asks court for halt of Novartis unit’s generic launch
04-04-2022
Roche and AstraZeneca units settle blood drug suit
17-02-2022
PTAB: Roche patent can’t evade IPR under Fintiv
11-01-2022
Judge cuts ‘disproportionate’ £1.7m costs claim by Roche
27-07-2021
